Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL

NCT06375733

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Guangxi Medical University Cancer Hospital&Guangxi Cancer Institute Nanning, China

Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital Zhengzhou, China

View Trial Details

Recruiting

IA Carboplatin + Radiotherapy in Relapsing GBM

NCT03672721

Conditions: Astrocytoma, Disease Attributes, Glioblastoma, +13 more
Locations: CHUS Sherbrooke, Quebec, Canada

View Trial Details

Recruiting

Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT04684147

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Beijing Boren Hospital Beijing, Beijing Municipality, China

Xinqiao Hospital of TMMU Chongqing, Chongqing Municipality, China

Nanfang Hospital Guangzhou, Guangdong, China

Yanda hospital, Hebei medical university Sanhe, Hebei, China

View Trial Details

Recruiting

Sirolimus in the Treatment of Refractory/Relapsed wAIHA

NCT05925023

Conditions: Disease Attributes, Evans Syndrome, Pathologic Processes, +3 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma

NCT06356883

Conditions: Astrocytoma, Disease Attributes, Glioblastoma, +13 more
Locations: CHUS Sherbrooke, Quebec, Canada

View Trial Details

Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT06340737

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia

NCT06265545

Conditions: AML, Disease Attributes, Pathologic Processes, +4 more
Locations: Blood Hospital Tianjin, China

View Trial Details

Recruiting

Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies

NCT05457595

Conditions: Adnexal Diseases, Carcinoma, Disease Attributes, +25 more
Locations: CNAO Pavia, Pv, Italy

View Trial Details

Recruiting

Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL

NCT05554939

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: School of phamaceutical, Tsinghua University Beijing, Beijing Municipality, China

Biotherapeutic Department, Chinese PLA General Hospital Beijing, China

View Trial Details

Recruiting

Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia

NCT07105579

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: First Affiliated Hospital of Zhejiang University Hangzhou, China

View Trial Details

Recurrence

Recurrence trial results

Related conditions